🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Familial Cancer

Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study NCT07640048n/a1 site📍 Beijing Peking Union Medical College Hospital · Tests: Adebrelimab, Gemcitabine, Cisplatin, S-1, Apatinib Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers NCT06409065NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Meditation Program Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers NCT06524973NA22 sites📍 Arcadia📍 Corona📍 Duarte City of Hope Medical Center · Tests: Telemedicine, Counseling, Best Practice, Questionnaire Administration, Inrweview Low-Dose Sirolimus for the Treatment of RUNX1 Familial Platelet Disorder NCT07844694Phase 11 site📍 Portland OHSU Knight Cancer Institute · Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Questionnaire Administration, Sirolimus Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux NCT06746623NA1 site📍 Cleveland Louis Stokes VA Medical Center · Tests: Enrolled participants will complete Esocheck/Esoguard and diagnostic upper endoscopy. Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP) NCT06641310NA2 sites📍 Ann Arbor📍 Cleveland University of Michigan Rogel Cancer Center · Tests: Exercise Therapy Trial of Combined Obstetric Carrier Screening and Hereditary Cancer Screening NCT07052266NA5 sites📍 Brooklyn📍 Brooklyn📍 New York Weill Medical College of Cornell University · Tests: MyRisk Hereditary Cancer Test Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents NCT05151718n/a1 site📍 Toulouse Institut Claudius Regaud Implementation of eHealth Delivery Alternatives for Cancer Genetic Testing for Hereditary Cancer (eREACH3) NCT07471958n/a1 site📍 Philadelphia Abramson Cancer Center at Penn Medicine Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis NCT06950385Phase 329 sites📍 Arcadia📍 New Haven📍 Washington D.C. Rapamycin Holdings Inc. · Tests: eRapa (encapsulated rapamycin), Placebo Screening for Lung Cancer in Subjects With Family History of Lung Cancer NCT05762731n/a1 site📍 Hong Kong The University of Hong Kong · Tests: Low dose CT thorax, Low dose CT thorax An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis NCT06557733Phase 24 sites📍 Phoenix📍 Rochester📍 Salt Lake City National Cancer Institute (NCI) · Tests: Biopsy Procedure, Biospecimen Collection, EP2/EP4 Antagonist TPST-1495, Esophagogastroduodenoscopy, Gastrointestinal En… Essen Amyloidosis Registry NCT06887283n/a1 site📍 Essen University Hospital, Essen Impact of Environmental Exposures on Tumor Risk in SDHx-mutation Carriers NCT06408402n/a20 sites📍 Angers📍 Besançon📍 Bron Assistance Publique - Hôpitaux de Paris Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency NCT06090669Phase 11 site📍 Bethesda National Cancer Institute (NCI) · Tests: TruSight Oncology, imatinib Goal Attainment Scale in Transplantation NCT07372690NA1 site📍 Torino Azienda Ospedaliera Ospedale Infantile Regina Margherita Sa… · Tests: GAS group, control group Genotype-phenotype Relationship Between Cryptogenic Cholestasis and Familial Intrahepatic Cholestasis NCT06781242n/a2 sites📍 Bologna📍 Modena IRCCS Azienda Ospedaliero-Universitaria di Bologna An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results NCT05420064NA8 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Intervention Arm At-risk Relative/ARR Contacts, MyGene Portal, Standard of Care Increasing Germline Genetic Testing for Patients With Cancer NCT07307664NA10 sites📍 Los Angeles📍 Orlando📍 Decatur Josh Peterson · Tests: Implementation strategies Ready for Safe Cancer Treatment (RESET): A Comprehensive Perioperative Program for Surgical Oncology NCT07727876NA2 sites📍 Wroclaw📍 Wroclaw Regional Specialist Hospital in Wroclaw · Tests: RESET multimodal perioperative care pathway, Standard perioperative care Compassion-Based Intervention for Lung Cancer Caregivers (CBI-LCC) NCT06930313NA1 site📍 Taipei Taipei Medical University · Tests: Brief Compassion-Based Intervention (BCI), Telephone-Based Support and Education (TSE) Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders NCT06147414n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Blood sample Taiwan Real-world LDCT Screening Behavior and Outcome Research for High Risk Subjects Based on Health Promotion Administration NCT05557487n/a7 sites📍 Taichung📍 Hsinchu📍 Hualien City Gee-Chen Chang · Tests: Low dose computed tomography Influence of Art Workshops and Cognitive Support for Families of Children With Cancer. NCT07878078Phase 31 site📍 Cairo Children's Cancer Hospital Egypt 57357 · Tests: Art Workshops and Cognitive Support Sessions. Implementation of Population Cancer Genetic Services in Federally Qualified Health Centers (FQHC) NCT05664867NA1 site📍 Chicago University of Illinois at Chicago · Tests: Mainstream Genetic Testing Model, Enhanced Standard of Care Model Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma NCT00040352n/a2 sites📍 Bethesda📍 Bethesda National Cancer Institute (NCI) Genetic Assessment of Breast Cancer Risk in Women in the DORA Programme NCT07734389NA1 site📍 Ljubljana Institute of Oncology Ljubljana · Tests: Comprehensive Clinical and Genetic Breast Cancer Risk Assessment Liver Transplantation for Unresectable Intrahepatic Colangiocarcinoma After Sustained Response to Neoadjuvant Treatments NCT06862934n/a1 site📍 Milan Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Protective Mechanisms of Phycocyanin in Partial Hepatectomy-Associated Liver Injury NCT07760038NA1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Phycocyanin, Maltodextrin Lynch Syndrome X-Talk of Enteral Mucosa With Immune System NCT06708429n/a5 sites📍 Monrovia📍 Milan📍 Milan San Raffaele University · Tests: LYNX EYE (Lynch syndrome X-Talk of Enteral mucosa with Immune System)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy